# TP53AIP1

## Overview
TP53AIP1, or tumor protein p53 regulated apoptosis inducing protein 1, is a gene that encodes a protein involved in the regulation of apoptosis, particularly in response to cellular stress and DNA damage. The protein encoded by TP53AIP1 is primarily localized to the mitochondrial membrane, where it plays a crucial role in the intrinsic pathway of apoptosis by facilitating the release of cytochrome c, thereby activating caspases and promoting programmed cell death (Luedeke2012Prostate). The expression of TP53AIP1 is tightly regulated by the tumor suppressor protein p53, specifically through phosphorylation at serine 46, which is essential for its pro-apoptotic function (Oda2000p53AIP1). This gene is significant in maintaining cellular homeostasis and preventing the proliferation of damaged cells, thus contributing to tumor suppression. Alterations in TP53AIP1 expression have been associated with various cancers, highlighting its potential as a prognostic marker and therapeutic target (Yamashita2008p53AIP1; Liang2019Overexpression).

## Function
TP53AIP1, also known as tumor protein p53 regulated apoptosis inducing protein 1, is a gene that plays a significant role in p53-dependent apoptotic signaling. It is primarily localized in the mitochondrial membrane, where it mediates apoptosis through the release of cytochrome c, a critical step in the activation of caspases and the execution of programmed cell death (Luedeke2012Prostate). The expression of TP53AIP1 is induced by the phosphorylation of the p53 protein at serine 46, which is essential for its role in apoptosis (Oda2000p53AIP1). This phosphorylation event is crucial for the proper function of TP53AIP1, as it regulates the gene's expression in response to cellular stress, such as DNA damage (Oda2000p53AIP1).

In healthy human cells, TP53AIP1 is involved in maintaining cellular homeostasis by regulating apoptosis, thereby preventing the proliferation of damaged cells and contributing to tumor suppression (Luedeke2012Prostate). The gene's activity in the mitochondria underscores its role in the intrinsic pathway of apoptosis, highlighting its importance in cellular processes that ensure the removal of potentially harmful cells (Oda2000p53AIP1).

## Clinical Significance
Alterations in the expression of TP53AIP1 have been implicated in various cancers. In non-small cell lung cancer (NSCLC), reduced expression of TP53AIP1 is associated with lymph node metastasis and poorer overall survival rates, suggesting its potential as an independent prognostic marker (Yamashita2008p53AIP1). Similarly, in breast cancer, TP53AIP1 expression is significantly lower in tumor tissues compared to adjacent non-tumor tissues. Overexpression of TP53AIP1 in breast cancer cell lines has been shown to inhibit cell viability, induce cell cycle arrest, and promote apoptosis, indicating its role as a tumor suppressor (Liang2019Overexpression).

In lung adenocarcinoma, miR-505-5p targets TP53AIP1, inhibiting its expression and thereby reducing apoptosis, which contributes to cancer progression (Fang2019Extracellular). Germline mutations in TP53AIP1, such as p.Gln22fs and p.Ser32X, have been identified in hereditary breast and ovarian cancer, although their role in prostate cancer remains unclear (Chaudhry2021Germline; Luedeke2012Prostate). These findings highlight the clinical significance of TP53AIP1 in cancer prognosis and therapy.

## Interactions
TP53AIP1 is a downstream target gene of the tumor suppressor protein p53 and plays a significant role in the p53-dependent apoptosis pathway. It is involved in the regulation of apoptosis through its interactions with the chondriosome pathway, which is part of the endogenous apoptosis pathway. TP53AIP1 affects the chondriosome membrane potential and induces the release of cytochrome c, promoting apoptosis in tumor cells (Liu2017Effects).

In the context of DNA damage-induced apoptosis, TP53AIP1 is transcriptionally activated by the YAP-p73 complex. YAP functions as a transcriptional coactivator of p73, enhancing its ability to activate pro-apoptotic genes, including TP53AIP1. This interaction involves the WW domain of YAP and the PPPY motif of p73, with YAP competing with the E3 ubiquitin ligase ITCH for binding to p73. The YAP-p73 complex is crucial for the transcriptional activation of TP53AIP1, particularly in response to DNA-damaging agents like cisplatin (Raj2019Reciprocal).

These interactions highlight the role of TP53AIP1 in mediating apoptosis through its involvement in the p53 signaling pathway and its regulation by other proteins such as YAP and p73.


## References


[1. (Liu2017Effects) Kai Liu, Xinke Zhao, Jing Gu, Jianjun Wu, Hong Zhang, and Yingdong Li. Effects of c heavy ion beam irradiation on the p53 signaling pathway in hepg2 liver cancer cells. Acta Biochimica et Biophysica Sinica, 49(11):989–998, September 2017. URL: http://dx.doi.org/10.1093/abbs/gmx096, doi:10.1093/abbs/gmx096. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/abbs/gmx096)

[2. (Raj2019Reciprocal) Nitin Raj and Rakesh Bam. Reciprocal crosstalk between yap1/hippo pathway and the p53 family proteins: mechanisms and outcomes in cancer. Frontiers in Cell and Developmental Biology, August 2019. URL: http://dx.doi.org/10.3389/fcell.2019.00159, doi:10.3389/fcell.2019.00159. This article has 64 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2019.00159)

[3. (Yamashita2008p53AIP1) S.-i. Yamashita, Y. Masuda, N. Yoshida, H. Matsuzaki, T. Kurizaki, Y. Haga, S. Ikei, M. Miyawaki, Y. Kawano, M. Chujyo, and K. Kawahara. P53aip1 expression can be a prognostic marker in non-small cell lung cancer. Clinical Oncology, 20(2):148–151, March 2008. URL: http://dx.doi.org/10.1016/j.clon.2007.08.006, doi:10.1016/j.clon.2007.08.006. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.clon.2007.08.006)

[4. (Chaudhry2021Germline) Sophia R. Chaudhry, Jaime Lopes, Nancy K. Levin, Hasini Kalpage, and Michael A. Tainsky. Germline mutations in apoptosis pathway genes in ovarian cancer; the functional role of a tp53i3 (pig3) variant in ros production and dna repair. Cell Death Discovery, March 2021. URL: http://dx.doi.org/10.1038/s41420-021-00442-y, doi:10.1038/s41420-021-00442-y. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-021-00442-y)

[5. (Luedeke2012Prostate) Manuel Luedeke, Irina Coinac, Carmen M. Linnert, Natalia Bogdanova, Antje E. Rinckleb, Mark Schrader, Walther Vogel, Josef Hoegel, Andreas Meyer, Thilo Dörk, and Christiane Maier. Prostate cancer risk is not altered by tp53aip1 germline mutations in a german case-control series. PLoS ONE, 7(3):e34128, March 2012. URL: http://dx.doi.org/10.1371/journal.pone.0034128, doi:10.1371/journal.pone.0034128. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0034128)

[6. (Oda2000p53AIP1) Katsutoshi Oda, Hirofumi Arakawa, Tomoaki Tanaka, Koichi Matsuda, Chizu Tanikawa, Toshiki Mori, Hiroyuki Nishimori, Katsuyuki Tamai, Takashi Tokino, Yusuke Nakamura, and Yoichi Taya. P53aip1, a potential mediator of p53-dependent apoptosis, and its regulation by ser-46-phosphorylated p53. Cell, 102(6):849–862, September 2000. URL: http://dx.doi.org/10.1016/s0092-8674(00)00073-8, doi:10.1016/s0092-8674(00)00073-8. This article has 905 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0092-8674(00)00073-8)

[7. (Liang2019Overexpression) Yueyang Liang, Shushu Wang, and Jia Liu. Overexpression of tumor protein p53-regulated apoptosis-inducing protein 1 regulates proliferation and apoptosis of breast cancer cells through the pi3k/akt pathway. Journal of Breast Cancer, 22(2):172, 2019. URL: http://dx.doi.org/10.4048/jbc.2019.22.e21, doi:10.4048/jbc.2019.22.e21. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.4048/jbc.2019.22.e21)

[8. (Fang2019Extracellular) Hua Fang, Yutao Liu, Yaohong He, Yang Jiang, Yaping Wei, Han Liu, Yueqing Gong, and Guangyu An. Extracellular vesicle‑delivered mir‑505‑5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting tp53aip1. International Journal of Oncology, March 2019. URL: http://dx.doi.org/10.3892/ijo.2019.4738, doi:10.3892/ijo.2019.4738. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijo.2019.4738)